ARMATA PHARMACEUTICALS, INC. (ARMP) Operating income 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual operating income history from SEC filings — each fiscal year as reported.
-$36.6MFY2025 · since FY2016: -$23.4M → -$36.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.6M | +13.7% |
| FY2024 | -$42.4M | -3.8% |
| FY2023 | -$40.9M | -10.7% |
| FY2022 | -$36.9M | -55.1% |
| FY2021 | -$23.8M | -10.4% |
| FY2020 | -$21.6M | -9.3% |
| FY2019 | -$19.8M | -11.9% |
| FY2018 | -$17.7M | -9.3% |
| FY2017 | -$16.2M | +30.9% |
| FY2016 | -$23.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice